UK Biobank has today announced the launch of the world's most comprehensive study of the proteins circulating in our bodies, which will transform the study of diseases and their treatments.
Ultima Genomics, Inc., a developer of an ultra-high throughput next-generation sequencing (NGS) platform, today announced that its UG 100tm was selected as the sequencing platform to enable UK Biobank ...
Ultima Genomics, Inc., a developer of an ultra-high throughput next-generation sequencing (NGS) platform, today announced that its UG 100™ was selected as the sequencing platform to enable UK ...
UK Biobank has today announced the launch of the world’s most comprehensive study of the proteins circulating in our bodies, which will transform the study of diseases and their treatments.